Big Tech is preventing new stock-market highs as investors change the way they play AI, says this top strategistJune 11, 2026
Neurocrine wants to develop new obesity drugs. It’s reportedly nearing an acquisition to accelerate that move. Personal Finance April 6, 2026 Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy…
